129 related articles for article (PubMed ID: 7436702)
1. [Value of DNFB skin testing in patients with bladder cancer (author's transl)].
Hudemann B; Seyfarth M
Arch Geschwulstforsch; 1980; 50(2):173-7. PubMed ID: 7436702
[TBL] [Abstract][Full Text] [Related]
2. [DNFB reaction in bladder cancer, an immunological study].
Hudemann B; Günther M; Seyfarth M
Z Urol Nephrol; 1979 Oct; 72(10):729-32. PubMed ID: 532391
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
Flamm J; Burkert S
Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
[TBL] [Abstract][Full Text] [Related]
4. The use of 1-fluoro-2,4-dinitrobenzene as an affinity label for the antigen receptor of delayed hypersensitivity.
Godfrey HP
Immunology; 1976 Oct; 31(4):665-73. PubMed ID: 789233
[TBL] [Abstract][Full Text] [Related]
5. Skin testing in genitourinary carcinoma: 2-year followup.
Decenzo JM; Allison R; Leadbetter GW
J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
[TBL] [Abstract][Full Text] [Related]
6. [Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)].
Stöber U
Urologe A; 1978 Sep; 17(5):296-302. PubMed ID: 309205
[TBL] [Abstract][Full Text] [Related]
7. Topical induction of delayed hypersensitivity in the bladder.
Burke C; Kumar V; Olsson CA
Invest Urol; 1979 May; 16(6):421-7. PubMed ID: 447475
[TBL] [Abstract][Full Text] [Related]
8. [The immunologic behavior of carcinoma in situ of the bladder].
Hudemann B; Riedel H; Seyfarth M; Werner H; Erdmann T
Z Urol Nephrol; 1982 Apr; 75(4):253-7. PubMed ID: 7102136
[TBL] [Abstract][Full Text] [Related]
9. DNCB and PPD skin testing in breast cancer.
Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
[TBL] [Abstract][Full Text] [Related]
10. [Use of a human embryonic antigen complex in studying the immune response in cancer patients].
Gorodilova VV; Mandrik EV; Ul'chenko VM
Vopr Onkol; 1982; 28(1):23-7. PubMed ID: 7199781
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
12. [Cellular immune reactions in patients with malignant tumors: correlation of phytohemagglutinin-induced lymphocyte transformation and epicutanous tests using dinitrofluorobenzene].
Schwarze G; Pappas A
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1852-4. PubMed ID: 1030123
[No Abstract] [Full Text] [Related]
13. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients.
Gumus E; Erdamar S; Demirel G; Horasanli K; Kendirci M; Miroglu C
Int J Urol; 2004 Dec; 11(12):1070-7. PubMed ID: 15663677
[TBL] [Abstract][Full Text] [Related]
14. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage].
Rodríguez Martínez JJ; Escaf Barmadah S; Allende MT; Raigoso P; Martín Benito JL; Pérez García FJ; Fernández Gómez JM
Arch Esp Urol; 2000; 53(1):1-6. PubMed ID: 10730418
[TBL] [Abstract][Full Text] [Related]
15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
16. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
Takanami I; Nakayama H; Ishihara T; Yanai N
Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
[TBL] [Abstract][Full Text] [Related]
17. Host immunocompetence in genitourinary cancer: relation to tumor stage and prognosis.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Natl Cancer Inst Monogr; 1978 Dec; (49):105-10. PubMed ID: 311891
[TBL] [Abstract][Full Text] [Related]
18. SPECIFICITY OF PASSIVELY TRANSFERRED DELAYED HYPERSENSITIVITY.
NAJARIAN JS; FELDMAN JD
J Exp Med; 1963 Sep; 118(3):341-52. PubMed ID: 14077995
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
